On Tuesday, Neuronetics Inc (NASDAQ: STIM) opened at On Tuesday, remained unchanged from the last session, before settling in for the closing price of $4.29. Price fluctuations for STIM have ranged from $0.52 to $5.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 4.64% annually for the last half of the decade. Company’s average yearly earnings per share was noted 74.17% at the time writing. With a float of $36.86 million, this company’s outstanding shares have now reached $65.82 million.
In an organization with 716 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 63.51%, operating margin of -43.29%, and the pretax margin is -53.68%.
Neuronetics Inc (STIM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Neuronetics Inc is 44.00%, while institutional ownership is 25.77%. The most recent insider transaction that took place on May 12 ’25, was worth 826,074. In this transaction EVP, CFO and Treasurer of this company sold 193,460 shares at a rate of $4.27, taking the stock ownership to the 416,593 shares. Before that another transaction happened on May 13 ’25, when Company’s EVP, CFO and Treasurer sold 6,540 for $4.16, making the entire transaction worth $27,206. This insider now owns 410,053 shares in total.
Neuronetics Inc (STIM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 74.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.20% during the next five years compared to 2.71% growth over the previous five years of trading.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Check out the current performance indicators for Neuronetics Inc (STIM). In the past quarter, the stock posted a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.7 million. That was inferior than the volume of 1.36 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 41.16%. Additionally, its Average True Range was 0.35.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 65.10%, which indicates a significant decrease from 65.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.95% in the past 14 days, which was lower than the 120.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.23, while its 200-day Moving Average is $2.35. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $4.44. Second resistance stands at $4.58. The third major resistance level sits at $4.70. If the price goes on to break the first support level at $4.17, it is likely to go to the next support level at $4.05. The third support level lies at $3.91 if the price breaches the second support level.
Neuronetics Inc (NASDAQ: STIM) Key Stats
There are currently 65,820K shares outstanding in the company with a market cap of 282.37 million. Presently, the company’s annual sales total 74,890 K according to its annual income of -43,710 K. Last quarter, the company’s sales amounted to 31,980 K and its income totaled -12,680 K.
